摘要 |
The present invention concerns the compounds of formula (I) , the substituents being specified in the description, (I) the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemical Iy isomeric forms thereof , and their use for the manufacture of a medicament for the treatment of mental disorders, preferably schizophrenia. |
申请人 |
JANSSEN PHARMACEUTICA N.V.;KENNIS, LUDO, EDMOND, JOSEPHINE;VANHOOF, GRETA, CONSTANTIA, PETER;BONGARTZ, JEAN-PIERRE, ANDRE, MARC;LUYCKX, MARCEL, GEREBERNUS, MARIA;MINKE, WENDA, EVELINE |
发明人 |
KENNIS, LUDO, EDMOND, JOSEPHINE;VANHOOF, GRETA, CONSTANTIA, PETER;BONGARTZ, JEAN-PIERRE, ANDRE, MARC;LUYCKX, MARCEL, GEREBERNUS, MARIA;MINKE, WENDA, EVELINE |